Intrapleural Hemocoagulase and Early Outcomes After VATS for Stage IA NSCLC

A retrospective analysis of 442 stage IA non-small cell lung cancer patients undergoing video-assisted thoracoscopic surgery, comparing outcomes between those receiving intrapleural Hemocoagulase Bothrops atrox and a control group. The dataset includes coagulation profiles, complication rates, and hospital stay length, authored by Yingding Ruan and last updated in April 2026. The study employed inverse probability of treatment weighting to balance baseline characteristics.

Use Cases

• Analyzing the association between intrapleural hemocoagulase and postoperative coagulation profiles based on prothrombin time and fibrinogen levels.
• Modeling the impact of a specific surgical intervention on complication rates after video-assisted thoracoscopic surgery.
• Investigating factors correlated with shorter postoperative hospital stays in early-stage lung cancer patients.

Strengths

• Dataset includes 442 patient records, providing a substantial sample for analysis.
• Analysis employed statistical balancing (inverse probability of treatment weighting) to address confounding.
• Specific numerical results for key outcomes are reported, such as a 6.5% vs. 12.0% complication rate.

Limitations

• Row count for the underlying data table is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect temporal or institutional bias inherent to the single retrospective study.

Provenance

Source

Yingding Ruan via figshare

Collection Method

Retrospective analysis of patient records.

Time Range

Temporal coverage of the underlying patient data is not specified.

Freshness

Last updated 2026-04-10 05:29:35; freshness should be verified.

Geography

Spatial coverage of the patient population is not specified.